Industry Analysis & Industry Trends
The Biotechnology industry investigates, develops and capitalises on the commercial applications of biological manipulation. It is fast becoming a prominent part of the UK life science sector, alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it increasingly difficult to identify the boundaries between them. The industry relies on third-party financing, so the economic downturn and its lasting effects posed significant funding challenges during many years of the past five-year period. This dampened growth, but could not contain it. Britain’s ageing population requires advanced treatment options to ward off decline, which benefited the Biotechnology industry... purchase to read more
Industry Report - Industry Products Chapter
The industry's dependence on third-party financiers has cultivated innovation because firms have to compete for funding. The result has been rapid changes in product and service offerings as the industry seeks to satisfy demand for cutting-edge technologies. The industry currently concentrates on five broad areas.
Human health products
The human health product segment includes human therapeutics like biotechnology-derived proteins, antibodies and enzymes; genetic therapies; and diagnostics such as tests for specific gene or protein markers. As with other industry segments, the range and experience of companies in the human health product segment is diverse.
.. purchase to read more